FDPS: Human farnesyl diphosphate synthase in complex with risedronate
PDB Code: 1YV5, 1YQ7
A key branch point enzyme of the mevalonate pathway is farnesyl diphosphate synthase (FDPS, FPPS, EC, a Mg 2+ -dependent homodimeric enzyme, localized in peroxisomes. FDPS catalyzes the formation of both geranyl and farnesylpyrophosphate from isopentenylpyrophosphate and dimethylallyl pyrophosphate. Post-translational modification of C-terminal C AAX sequences by covalent attachment of these isoprenyl chains is crucial for intracellular localization and proper function of small GTPases such as Ras, Rac, Rho , and CDC42.
Interest in understanding FDPS activity stems from the recent discovery that FDPS is the molecular target of nitrogen-containing bisphosphonates. These compounds disrupt cell growth through FDPS inhibition in parasitic organisms in vitro. In humans, bisphosphonates are targeted to bone tissue where FDPS inhibition in bone-resorbing osteoclasts is a current therapeutic approach for treating post-menopausal osteoporosis. Because of their bone-targeting properties, bisphosphonates have also found use as agents to treat tumor-induced hypercalcemia, Paget’s disease, and osteolytic metastases.

Welcome to buy

This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@biochemical-bc.net
2. Tel: +86 592 5365887
3.WhatsApp: +86 189 6515 7632
4. Send enquiry online

Please feel free to for: the product
Quotation the product,required sepecifications,inquire about MOQ,
New Sales Promotion,New Products,And any other assistance.

You may also be interested in :

For more information of product, please send the email to sales@biochemical-bc.net